Skip to main content
. 2018 Nov 20;290(1):9–22. doi: 10.1148/radiol.2018181349

Figure 5:

Figure 5:

Immune-related hypophysitis in a 56-year-old woman with metastatic melanoma receiving ipilimumab and nivolumab and with headaches at presentation. Coronal MR image after 8 weeks of ipilimumab and nivolumab therapy shows an enlarged pituitary gland (*) and infundibular thickening (arrow), representing immune-related hypophysitis. The symptom and findings resolved after corticosteroid therapy.